Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease.

Woolsey SJ, Beaton MD, Mansell SE, Leon-Ponte M, Yu J, Pin CL, Adams PC, Kim RB, Tirona RG.

Mol Pharmacol. 2016 Oct;90(4):437-46. doi: 10.1124/mol.116.104687. Epub 2016 Aug 1.

PMID:
27482056
2.

Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects.

Woolsey SJ, Beaton MD, Choi YH, Dresser GK, Gryn SE, Kim RB, Tirona RG.

Basic Clin Pharmacol Toxicol. 2016 Apr;118(4):284-91. doi: 10.1111/bcpt.12492. Epub 2015 Oct 14.

3.

CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease.

Woolsey SJ, Mansell SE, Kim RB, Tirona RG, Beaton MD.

Drug Metab Dispos. 2015 Oct;43(10):1484-90. doi: 10.1124/dmd.115.065979. Epub 2015 Jul 31.

PMID:
26231377

Supplemental Content

Loading ...
Support Center